The earnings call highlighted significant progress in technology development and strategic initiatives to address market challenges. Although revenue was impacted by external uncertainties, the company has introduced new strategies to adapt and maintain financial strength. While there are challenges, the advancements in product offerings and strong cash position provide a positive outlook.

Company Guidance -

Q3 2025

During the Quantum-Si Q2 2025 earnings call, the company reported revenue of $591,000, driven primarily by consumable sales despite a halt in capital purchases by U.S. academic labs due to NIH funding uncertainties. The gross profit was $351,000, with a gross margin of 59%. The company expanded its funnel of opportunities in the pharma and biotech sectors, doubling from approximately 30 to over 60 prospects. They launched new instrument acquisition options to overcome capital sales challenges, including leasing and reagent rental models, and secured initial customers with these alternatives. Quantum-Si also made progress on its innovation road map, with the upcoming release of their version 4 sequencing kit and version 3 library preparation kit, aiming to enhance proteome coverage and sample processing capabilities. They reported $214.2 million in cash and marketable securities, with a runway into Q2 2028, following a $50 million registered direct offering. The company revised its 2025 guidance for adjusted operating expenses to $98 million or less.

Increase in Pharma and Biotech Opportunities

The commercial team more than doubled the funnel of opportunities in the pharma and biotech segments from approximately 30 at the end of the first quarter to more than 60 at the end of the second quarter of 2025.

Launch of Expanded Instrument Acquisition Options

Quantum-Si introduced new acquisition options for their Platinum Pro instrument to address capital sales headwinds, allowing customers to acquire instruments without upfront capital, thereby capturing consumable revenue.

Proteus Development Program Milestones

Significant progress in the Proteus development program, including additional dye development and feasibility of wafer-scale surface chemistry processing, setting up for a successful launch in the second half of 2026.

AI-Based Recognizer Design Success

Completed the first AI-based recognizer design, achieving a binder that meets specifications within one design cycle, significantly shortening the timeline to produce candidate binders.

Post-Translational Modifications (PTM) Detection

Successfully developed a combined method for PTM detection that has met internal technology feasibility thresholds and transferred to product development for commercial kits.

Strong Financial Position

As of June 30, 2025, the company had $214.2 million in cash, cash equivalents, and marketable securities, providing runway into the second quarter of 2028.

Quantum-Si (QSI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

QSI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	-0.13 / -	-0.18	―	―	―
Aug 05, 2025	2025 (Q2)	-0.14 / -0.16	-0.16	0.00% (0.00)	―
May 15, 2025	2025 (Q1)	-0.15 / -0.11	-0.14	21.43% (+0.03)	―
Mar 03, 2025	2024 (Q4)	-0.18 / -0.23	-0.16	-43.75% (-0.07)	―
Nov 12, 2024	2024 (Q3)	-0.20 / -0.18	-0.17	-5.88% (>-0.01)	―
Aug 07, 2024	2024 (Q2)	-0.18 / -0.16	-0.18	11.11% (+0.02)	―
May 09, 2024	2024 (Q1)	-0.20 / -0.14	-0.17	17.65% (+0.03)	―
Feb 29, 2024	2023 (Q4)	-0.17 / -0.16	-0.24	33.33% (+0.08)	―
Nov 09, 2023	2023 (Q3)	-0.18 / -0.17	-0.23	26.09% (+0.06)	―
Aug 07, 2023	2023 (Q2)	-0.17 / -0.18	-0.23	21.74% (+0.05)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

QSI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$1.44	$1.37	-4.86%
May 15, 2025	$1.48	$1.48	0.00%
Mar 03, 2025	$1.30	$1.38	+6.15%
Nov 12, 2024	$1.00	$0.78	-22.00%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Quantum-Si (QSI) report earnings?

Quantum-Si (QSI) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Quantum-Si (QSI) earnings time?

Quantum-Si (QSI) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is QSI EPS forecast?

QSI EPS forecast for the fiscal quarter 2025 (Q3) is -0.13.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing